BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//N2 Canada - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:N2 Canada
X-ORIGINAL-URL:https://n2canada.ca
X-WR-CALDESC:Events for N2 Canada
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Edmonton
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20230312T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20231105T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20240310T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20241103T080000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0700
TZOFFSETTO:-0600
TZNAME:MDT
DTSTART:20250309T090000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0600
TZOFFSETTO:-0700
TZNAME:MST
DTSTART:20251102T080000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Winnipeg
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Edmonton:20241213T060000
DTEND;TZID=America/Edmonton:20241213T070000
DTSTAMP:20241119T200525Z
CREATED:20241119T200525Z
LAST-MODIFIED:20241119T200525Z
UID:14080-1734069600-1734073200@n2canada.ca
SUMMARY:Webinar: WHO launches new clinical trials guidance – What do I need to know?
DESCRIPTION:The publication of the WHO guidance for best practices for clinical trials in September 2024 was a major milestone. For the first time there is now global guidance applicable to design and conduct of all clinical trials (whether or not they include investigational products)\, also with relevance to observational studies. \nKey areas of focus include embedding research into health systems\, developing sustained networks of continuously active clinical researchers\, greater inclusivity of diverse population groups\, the centrality of the need for interaction between patient/community groups and researchers in the trial life cycle\, simplifying what can be excessively complex and uncoordinated clinical trial approval processes involving many bodies\, and ensuring a risk-based\, proportionate approach to design\, data collection\, oversight and inspection. WHO and The Global Health Network are convening a global event to present the key aspects of this new guidance. \nThis will be an informative opportunity to hear directly from WHO and learn how this guidance can help support and strengthen your research. Live translation will be available.
URL:https://n2canada.ca/event/who-webinar/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/11/Event-Posters-for-Website-LinkedIn-Post.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241121T080000
DTEND;TZID=America/Toronto:20241121T170000
DTSTAMP:20250131T222820Z
CREATED:20240610T235750Z
LAST-MODIFIED:20250131T222820Z
UID:12978-1732176000-1732208400@n2canada.ca
SUMMARY:2024 Investigator Training Program (ITP) - Safety in Clinical Trials
DESCRIPTION:We are excited to announce that “Pan-Canadian Research Connect” is once again offering the Investigator Training Program (ITP) in collaboration with Pfizer. This year\, the program will feature 7 comprehensive modules designed to provide an in-depth overview of the clinical trial process\, offering practical recommendations to enhance the efficiency of clinical trial conduct. \nThe ITP is an excellent opportunity for clinical trial investigators and research staff who are new to clinical trials or who could benefit from a refresher course. Participation and registration are open to all researchers and the research community within the Research Connect Network. Those who attend all seven modules will be eligible to receive a TransCelerate Good Clinical Practices (GCP) Certificate. \nKey Highlights for 2024: \n\nComplete 7 Modules for Certification: This year’s program consists of 7 modules. Full attendance at all modules is required to receive the formal certificate.\nRegister Early: Registration is limited to 500 participants. Please ensure your participation by registering as soon as possible. If you are unable to attend\, kindly cancel your registration to allow others the opportunity to participate.\nMandatory Full Attendance: To obtain the certificate of completion from Pfizer and TransCelerate\, you must attend the entire duration of all 7 modules. Attendance from the start to the end of each webinar is necessary. Missing even 15 minutes may disqualify you from receiving the certificate.\nPre-read Materials: Some modules will have pre-read materials that will be sent to all registered attendees. We strongly encourage an in-depth review of these materials prior to attending the training.\nRetake Requirement for Certification: If you missed any portion of the training last year\, you are required to retake all the modules again this year to receive a formal certificate.\nOptional Refresher: Those who participated last year and wish to retake the modules as a refresher are more than welcome to do so.\n\nSchedule: The webinars will be held from November 12th to November 21st. \nPlease register as soon as possible for this exciting and limited opportunity.
URL:https://n2canada.ca/event/2024-investigator-training-program-itp-safety-in-clinical-trials/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/webp:https://n2canada.ca/wp-content/uploads/2024/06/Webinar-2-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241119T110000
DTEND;TZID=America/Toronto:20241119T121500
DTSTAMP:20250131T222948Z
CREATED:20240610T235504Z
LAST-MODIFIED:20250131T222948Z
UID:12976-1732014000-1732018500@n2canada.ca
SUMMARY:2024 Investigator Training Program (ITP) - Study Oversight Informed Consent
DESCRIPTION:We are excited to announce that “Pan-Canadian Research Connect” is once again offering the Investigator Training Program (ITP) in collaboration with Pfizer. This year\, the program will feature 7 comprehensive modules designed to provide an in-depth overview of the clinical trial process\, offering practical recommendations to enhance the efficiency of clinical trial conduct. \nThe ITP is an excellent opportunity for clinical trial investigators and research staff who are new to clinical trials or who could benefit from a refresher course. Participation and registration are open to all researchers and the research community within the Research Connect Network. Those who attend all seven modules will be eligible to receive a TransCelerate Good Clinical Practices (GCP) Certificate. \nKey Highlights for 2024: \n\nComplete 7 Modules for Certification: This year’s program consists of 7 modules. Full attendance at all modules is required to receive the formal certificate.\nRegister Early: Registration is limited to 500 participants. Please ensure your participation by registering as soon as possible. If you are unable to attend\, kindly cancel your registration to allow others the opportunity to participate.\nMandatory Full Attendance: To obtain the certificate of completion from Pfizer and TransCelerate\, you must attend the entire duration of all 7 modules. Attendance from the start to the end of each webinar is necessary. Missing even 15 minutes may disqualify you from receiving the certificate.\nPre-read Materials: Some modules will have pre-read materials that will be sent to all registered attendees. We strongly encourage an in-depth review of these materials prior to attending the training.\nRetake Requirement for Certification: If you missed any portion of the training last year\, you are required to retake all the modules again this year to receive a formal certificate.\nOptional Refresher: Those who participated last year and wish to retake the modules as a refresher are more than welcome to do so.\n\nSchedule: The webinars will be held from November 12th to November 21st. \nPlease register as soon as possible for this exciting and limited opportunity.
URL:https://n2canada.ca/event/2024-investigator-training-program-itp-study-oversight-informed-consent/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/webp:https://n2canada.ca/wp-content/uploads/2024/06/Webinar-2-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241114T110000
DTEND;TZID=America/Toronto:20241114T123000
DTSTAMP:20250131T223034Z
CREATED:20240610T235249Z
LAST-MODIFIED:20250131T223034Z
UID:12974-1731582000-1731587400@n2canada.ca
SUMMARY:2024 Investigator Training Program (ITP) - Study Start-Up Conducting a Study
DESCRIPTION:We are excited to announce that “Pan-Canadian Research Connect” is once again offering the Investigator Training Program (ITP) in collaboration with Pfizer. This year\, the program will feature 7 comprehensive modules designed to provide an in-depth overview of the clinical trial process\, offering practical recommendations to enhance the efficiency of clinical trial conduct. \nThe ITP is an excellent opportunity for clinical trial investigators and research staff who are new to clinical trials or who could benefit from a refresher course. Participation and registration are open to all researchers and the research community within the Research Connect Network. Those who attend all seven modules will be eligible to receive a TransCelerate Good Clinical Practices (GCP) Certificate. \nKey Highlights for 2024: \n\nComplete 7 Modules for Certification: This year’s program consists of 7 modules. Full attendance at all modules is required to receive the formal certificate.\nRegister Early: Registration is limited to 500 participants. Please ensure your participation by registering as soon as possible. If you are unable to attend\, kindly cancel your registration to allow others the opportunity to participate.\nMandatory Full Attendance: To obtain the certificate of completion from Pfizer and TransCelerate\, you must attend the entire duration of all 7 modules. Attendance from the start to the end of each webinar is necessary. Missing even 15 minutes may disqualify you from receiving the certificate.\nPre-read Materials: Some modules will have pre-read materials that will be sent to all registered attendees. We strongly encourage an in-depth review of these materials prior to attending the training.\nRetake Requirement for Certification: If you missed any portion of the training last year\, you are required to retake all the modules again this year to receive a formal certificate.\nOptional Refresher: Those who participated last year and wish to retake the modules as a refresher are more than welcome to do so.\n\nSchedule: The webinars will be held from November 12th to November 21st. \nPlease register as soon as possible for this exciting and limited opportunity.
URL:https://n2canada.ca/event/2024-investigator-training-program-itp-study-start-up-conducting-a-study/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/webp:https://n2canada.ca/wp-content/uploads/2024/06/Webinar-2-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241114T073000
DTEND;TZID=America/Toronto:20241115T161000
DTSTAMP:20240604T213330Z
CREATED:20240603T222024Z
LAST-MODIFIED:20240604T213330Z
UID:12490-1731569400-1731687000@n2canada.ca
SUMMARY:DIA Canada Annual Meeting
DESCRIPTION:The DIA Canada Annual Meeting will deliver a comprehensive overview of the current pharmaceutical\, medical device\, and/or diagnostic landscapes in Canada\, while sharing insights into Canada’s broader role in global healthcare product development and is separated into three tracks: Regulatory\, Clinical and Safety and Pharmacovigilance. This meeting will connect attendees with leaders and experts in academia and those involved in the regulatory\, clinical\, and safety and pharmacovigilance functional areas in the pharmaceutical and medical device industry to explore best practices\, lessons learned\, and problem-solving strategies effecting stakeholders in Canada. \nN2 Members\, please contact n2@n2canada.ca to receive a discount code for registration. 
URL:https://n2canada.ca/event/dia-canada-annual-meeting/
LOCATION:3 Bd du Casino\, 3 Bd du Casino\, Gatineau\, Quebec\, J8Y 6X4\, Canada
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/Webinar-8.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241114
DTEND;VALUE=DATE:20241115
DTSTAMP:20240816T193018Z
CREATED:20240816T193018Z
LAST-MODIFIED:20240816T193018Z
UID:13469-1731542400-1731628799@n2canada.ca
SUMMARY:Putting Patients First 2024
DESCRIPTION:Putting Patients First (PPF) is an annual conference that advances learning communities to improve health systems. \nThis year\, Putting Patients First 2024 will take place on November 14\, 2024\, in Vancouver\, BC. There is no cost to attend. \nLeaders in the health and health research ecosystems\, from patients to policy makers\, are welcome. This includes health-care providers\, health system decision-makers\, patients\, people with lived experience of health issues and the health care system\, health researchers\, and students and trainees.
URL:https://n2canada.ca/event/putting-patients-first-2024/
LOCATION:Vancouver Marriott Pinnacle Downtown Hotel\, 1128 W Hastings St\, Vancouver\, BC\, V6E 4R5\, Canada
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/08/Event-Posters-for-Website-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241112T120000
DTEND;TZID=America/Toronto:20241112T130000
DTSTAMP:20241023T200634Z
CREATED:20241022T224534Z
LAST-MODIFIED:20241023T200634Z
UID:13861-1731412800-1731416400@n2canada.ca
SUMMARY:Right-Sizing Health Systems for Kids through Research Excellence
DESCRIPTION:If you’re interested in the future of pediatric healthcare\, consider registering for this enlightening webinar hosted by Children’s Healthcare Canada. They’ll delve into how health research is essential for advancing children’s health\, identifying emerging trends\, and innovating new models of care. This event will discuss the importance of integrating research excellence into healthcare systems\, ensuring that investments lead to meaningful improvements for children\, youth\, and families. It’s a great opportunity to learn about the role of research in creating a more accessible and equitable healthcare system tailored for the youngest generations in Canada!
URL:https://n2canada.ca/event/right-sizing-health-systems-for-kids-through-research-excellence/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/10/CHEER-WEBINAR.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241112T110000
DTEND;TZID=America/Toronto:20241112T121500
DTSTAMP:20250131T222603Z
CREATED:20240610T234954Z
LAST-MODIFIED:20250131T222603Z
UID:12969-1731409200-1731413700@n2canada.ca
SUMMARY:2024 Investigator Training Program (ITP) - Clinical Trials Overview Regional Regulation
DESCRIPTION:We are excited to announce that “Pan-Canadian Research Connect” is once again offering the Investigator Training Program (ITP) in collaboration with Pfizer. This year\, the program will feature 7 comprehensive modules designed to provide an in-depth overview of the clinical trial process\, offering practical recommendations to enhance the efficiency of clinical trial conduct. \nThe ITP is an excellent opportunity for clinical trial investigators and research staff who are new to clinical trials or who could benefit from a refresher course. Participation and registration are open to all researchers and the research community within the Research Connect Network. Those who attend all seven modules will be eligible to receive a TransCelerate Good Clinical Practices (GCP) Certificate. \nKey Highlights for 2024: \n\nComplete 7 Modules for Certification: This year’s program consists of 7 modules. Full attendance at all modules is required to receive the formal certificate.\nRegister Early: Registration is limited to 500 participants. Please ensure your participation by registering as soon as possible. If you are unable to attend\, kindly cancel your registration to allow others the opportunity to participate.\nMandatory Full Attendance: To obtain the certificate of completion from Pfizer and TransCelerate\, you must attend the entire duration of all 7 modules. Attendance from the start to the end of each webinar is necessary. Missing even 15 minutes may disqualify you from receiving the certificate.\nPre-read Materials: Some modules will have pre-read materials that will be sent to all registered attendees. We strongly encourage an in-depth review of these materials prior to attending the training.\nRetake Requirement for Certification: If you missed any portion of the training last year\, you are required to retake all the modules again this year to receive a formal certificate.\nOptional Refresher: Those who participated last year and wish to retake the modules as a refresher are more than welcome to do so.\n\nSchedule: The webinars will be held from November 12th to November 21st. \nPlease register as soon as possible for this exciting and limited opportunity.
URL:https://n2canada.ca/event/2024-investigator-training-program-itp-clinical-trials-overview-regional-regulation/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/webp:https://n2canada.ca/wp-content/uploads/2024/06/Webinar-2-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241106
DTEND;VALUE=DATE:20241108
DTSTAMP:20240708T211118Z
CREATED:20240603T203804Z
LAST-MODIFIED:20240708T211118Z
UID:12483-1730851200-1731023999@n2canada.ca
SUMMARY:2024 Clinical Trials Ontario Conference
DESCRIPTION:The CTO Clinical Trials Conference is a leading Canadian forum to drive innovation in clinical trials\, including leaders from the pharmaceutical and medical device industries\, academic and healthcare leaders\, representatives from patient groups\, health charities and research institutions. This annual event provides a unique opportunity for members of our multi-stakeholder sector to collaborate\, exchange knowledge and advance clinical trials.
URL:https://n2canada.ca/event/2024-clinical-trials-ontario-conference/
LOCATION:Hilton Toronto\, 145 Richmond Street West\, Toronto\, Ontario\, M5H 2L2\, Canada
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/CTO-Conference1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241028
DTEND;VALUE=DATE:20241030
DTSTAMP:20241007T235841Z
CREATED:20241007T235656Z
LAST-MODIFIED:20241007T235841Z
UID:13836-1730073600-1730246399@n2canada.ca
SUMMARY:8th Annual Patient-Centered Approach to Clinical Trials Conference
DESCRIPTION:The 8th Annual Patient-Centered Approach to Clinical Trials Conference is fast approaching and this year the theme is: How Are We Advancing Cancer Clinical Trials in Canada? This seminal pan-cancer conference continues to inform clinical trial networks\, researchers\, industry\, and academic trial sponsors\, HTA agencies\, Health Canada\, and national and international cancer patient groups to mention a few. \nThe objectives for this year’s Conference include the following: \n\nTo showcase Canada as fertile ground for Clinical Trials\nTo educate and update on the good work and investments underway that will accelerate the clinical trial landscape in Canada over the new 2 to 3 years \nTo discuss where we are winning/advancing in Canada and where/what are the key barriers that must be addressed \n\nThis year the Conference will be in Montreal on Oct 29-30\, and is being held at the Holiday Inn & Suites\, Montreal Centre-Ville Ouest. \nThe Conference is complementary and this is the Registration link:  https://tinyurl.com/PACT-2024
URL:https://n2canada.ca/event/8th-annual-patient-centered-approach-to-clinical-trials-conference/
LOCATION:Holiday Inn & Suites\, Montreal Centre-Ville Ouest.\, 1390 René-Lévesque Blvd W\, Montreal\, Quebec\, H3G 0E3\, Canada
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/10/Untitled-design.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Winnipeg:20241024T090000
DTEND;TZID=America/Winnipeg:20241024T150000
DTSTAMP:20241010T202625Z
CREATED:20240603T182334Z
LAST-MODIFIED:20241010T202625Z
UID:12405-1729760400-1729782000@n2canada.ca
SUMMARY:N2 Central Regional Meeting
DESCRIPTION:Register for the in-person Central N2 Canada Regional Meeting taking place in Winnipeg\, organized in collaboration with the C4T (The Canadian Collaborative for Childhood Cannabinoid Therapeutics)\, Centre for Healthcare Innovation\, Children’s Hospital Research Institute of Manitoba\, Research Manitoba\, University of Manitoba\, and the University of Saskatchewan. The theme for the event is surrounding Cannabis Trials. Please keep an eye out for details as they become available. \nWe have exciting news! Registration fees covered for Manitoba residents through a grant from Research Manitoba. If you are located outside of Manitoba\, please contact n2@n2canada.ca to process your registration.  \n 
URL:https://n2canada.ca/event/n2-central-regional-meeting/
LOCATION:SmartPark Innovation Hub\, 100 Innovation Dr.\, Winnipeg\, Manitoba\, R3T 6A8\, Canada
CATEGORIES:N2 Regional Meetings
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/Event-Posters-for-Website.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241023
DTEND;VALUE=DATE:20241024
DTSTAMP:20240603T203234Z
CREATED:20240603T203234Z
LAST-MODIFIED:20240603T203234Z
UID:12477-1729641600-1729727999@n2canada.ca
SUMMARY:7th Annual IGNITE Applied Health Research Conference
DESCRIPTION:
URL:https://n2canada.ca/event/7th-annual-ignite-applied-health-research-conference/
LOCATION:Barrie\, Barrie\, Ontario\, Canada
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/Webinar-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241022T130000
DTEND;TZID=America/Toronto:20241022T143000
DTSTAMP:20240918T212737Z
CREATED:20240918T210011Z
LAST-MODIFIED:20240918T212737Z
UID:13778-1729602000-1729607400@n2canada.ca
SUMMARY:N2 Canada 2025 Annual Conference Ideation Workshop
DESCRIPTION:The 2025 N2 Annual Conference will be held on a virtual platform from February 11-12\, 2025\, from 12:00-4:00 PM EST. The Annual Conference is being developed for our members\, and participating in this Conference Ideation Workshop is your opportunity to help shape next year’s conference! Registration in advance is required so that we can develop breakout rooms. \nWorkshop Objectives: \n1. Gather ideas from the N2 community for topics and speakers for the conference \n2. Generate and gather ideas from the N2 community on networking at the conference
URL:https://n2canada.ca/event/n2-canada-2025-annual-conference-ideation-workshop/
LOCATION:Zoom
CATEGORIES:N2 Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/09/A-workshop-on-tidiness.-1600-x-900-px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20241003T090000
DTEND;TZID=America/Toronto:20241003T170000
DTSTAMP:20240711T184114Z
CREATED:20240711T184011Z
LAST-MODIFIED:20240711T184114Z
UID:13168-1727946000-1727974800@n2canada.ca
SUMMARY:Adaptive Platform Trials Scientific Meeting
DESCRIPTION:The APT Scientific Meeting is for clinical trialists\, clinical investigators\, statisticians\, trial methodologists\, health economists\, trainees\, policymakers\, patient advocates\, and anyone interested in using\, designing\, and implementing platform trials. \nLearning objectives: \n\nUnderstand the key elements of designing and implementing an adaptive platform trial.\nGain insights into the operational aspects of adaptive platform trials\, such as protocol development\, CRF design\, data management\, and the role of standardization and operational documents.\nUnderstand the importance of pre-trial model-based simulations and interim statistical analyses for adaptive platform trials.\nLearn about the ethical considerations\, best practices\, and the role of Research Ethics Boards (REBs) in operationalizing ethical guidelines throughout adaptive platform trials.\nExplore strategies for effective engagement and involvement of participants\, including patients and other stakeholders\, in the adaptive platform trial process.\n\nScientific committee members: Drs. Andrew Pinto\, Benita Hosseini (Chair)\, Lisa Schwartz\, Robert Fowler\, and Shirin Golchi
URL:https://n2canada.ca/event/adaptive-platform-trials-scientific-meeting/
LOCATION:Chestnut Conference Centre\, 89 Chestnut Street\, Toronto\, Ontario\, M5G 1R1\, Canada
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/07/Event-Posters-for-Website-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240927
DTEND;VALUE=DATE:20240930
DTSTAMP:20240715T174821Z
CREATED:20240715T174821Z
LAST-MODIFIED:20240715T174821Z
UID:13217-1727395200-1727654399@n2canada.ca
SUMMARY:2024 SOCRA Annual Conference
DESCRIPTION:Join over 1\,000 of your colleagues at SOCRA’s Annual Conference! Each year\, SOCRA gathers clinical research professionals from around the world. Immerse yourself in this three-day conference filled with current information\, essential tools\, best practices\, and comprehensive training to ensure your clinical research practice remains up-to-date and compliant. The program boasts expert-led academic sessions\, interactive workshops\, ample networking opportunities\, a peer-driven poster session\, and an engaging exhibit program. Don’t miss this chance to connect\, learn\, and stay at the forefront of the industry. View agenda. \n 
URL:https://n2canada.ca/event/2024-socra-annual-conference/
LOCATION:Westgate Resort Las Vegas\, 3000 Paradise Road\, Las Vegas\, NV\, 89109\, United States
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/07/Event-Posters-for-Website-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240925T070000
DTEND;TZID=America/Toronto:20240925T083000
DTSTAMP:20240919T173912Z
CREATED:20240919T173315Z
LAST-MODIFIED:20240919T173912Z
UID:13792-1727247600-1727253000@n2canada.ca
SUMMARY:Launch webinar for WHO guidance for best practices for clinical trials
DESCRIPTION:Register for the WHO Webinar on 25 September which will launch the WHO guidance and detailed recommendations for national health authorities\, regulatory authorities\, funders and others on how best they can facilitate clinical trials and research. The guidance refers to several CIOMS documents. We are proud to say that the recommendations were adapted directly from the 2021 CIOMS Working Group report on Clinical research in resource-limited settings.
URL:https://n2canada.ca/event/launch-webinar-for-who-guidance-for-best-practices-for-clinical-trials/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/09/WHO-Webinar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20240917T120000
DTEND;TZID=America/Vancouver:20240917T130000
DTSTAMP:20240816T192348Z
CREATED:20240816T192348Z
LAST-MODIFIED:20240816T192348Z
UID:13465-1726574400-1726578000@n2canada.ca
SUMMARY:WHO Guidance for Best Practices for Clinical Trials
DESCRIPTION:Clinical trials have a central role in generating the evidence needed to inform the development and implementation of health interventions. This is because they can reliably determine whether a health intervention has any effect by ensuring that any biases or random errors inherent in the study design are small with respect to the expected treatment effect. The results have been transformative in advancing global public health.  \nThe intent of the ‘World Health Organization guidance for best practices for clinical trials’ document is to support implementation of universal ethical and scientific standards and strengthen the clinical trial ecosystem\, with a focus on under-represented populations. It is also complementary to other good clinical practice initiatives.  \nJoin us for an overview presentation on the WHO document which spans all regions and nations and is applicable across all health product lines: any design\, health intervention\, purpose\, setting and role.  \nTarget audience \nAny clinical trial staff member whose work is related to clinical trials in any way. This includes in planning\, conduct\, analysis\, oversight\, interpretation\, education and funding of all clinical trials in which randomization is used to assess the effects of any health intervention for any purpose in any setting.  \nLearning objectives \nThe learner will be able to:  \n\nhave an awareness of the main issues and steps required to facilitate good clinical trials and reduce waste\, \nidentify the qualities of a well-designed\, well-implemented and clinically relevant trial\, \nuse a framework and tools to self-evaluate whether a team has adequate infrastructure (physical and trial personnel) required to conduct an efficient high-quality trial\, \nlist the competencies that should be demonstrated by a clinical research team to undertake a successful study\, \nlead a discussion on the strenuous efforts needed to be made\, to recruit diverse populations to clinical trials.\n \n\nPresenter\n \n  \n  \n  \n  \n  \n  \nJean Smart\, PhD\, MGH\, MIDS \nRegulatory Affairs & Quality Officer\, Clinical Trials BC
URL:https://n2canada.ca/event/who-guidance-for-best-practices-for-clinical-trials/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/08/Event-Posters-for-Website.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240912T110000
DTEND;TZID=America/Toronto:20240912T120000
DTSTAMP:20240816T215611Z
CREATED:20240816T215611Z
LAST-MODIFIED:20240816T215611Z
UID:13473-1726138800-1726142400@n2canada.ca
SUMMARY:Pan-Canadian Research Connect Presents: ALS Breakthroughs: A New Dawn in Neurological Research
DESCRIPTION:Dr. Michael Strong will share groundbreaking insights into ALS research\, discussing the latest advancements and their implications for the future of neurological studies. \nThis is a unique opportunity to gain knowledge from one of the leading experts in the field and to engage in an enriching discussion with the research community about: \n\nThe current understanding of ALS\nThe latest discoveries in ALS pathogenesis\nRecent advancements in ALS research\nNew therapeutic approaches\n\nDr. Strong is a distinguished figure in the field of neurological research\, serving as the past president of the Canadian Institutes for Health Research. He is also a distinguished university professor at Western University\, dean emeritus of the Schulich School of Medicine and Dentistry\, and the Arthur J. Hudson Chair in ALS Research.
URL:https://n2canada.ca/event/pan-canadian-research-connect-presents-als-breakthroughs-a-new-dawn-in-neurological-research/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/08/Event-Posters-for-Website-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240912T084500
DTEND;TZID=America/Toronto:20240912T163000
DTSTAMP:20240625T230042Z
CREATED:20240531T200032Z
LAST-MODIFIED:20240625T230042Z
UID:12399-1726130700-1726158600@n2canada.ca
SUMMARY:N2 Eastern Regional Meeting
DESCRIPTION:Register for our in-person Eastern Regional meeting located in Oshawa. The event is being organized in collaboration with Lakeridge Health and will include topics on Advancing Clinical Research in Community Hospitals.
URL:https://n2canada.ca/event/n2-eastern-regional-meeting/
LOCATION:Lakeridge Health\, 1 Hospital Court\, Oshawa\, ON L1G 2B9\, 1 Hospital Court\, Oshawa\, Ontario\, L1G 2B9\, Canada
CATEGORIES:N2 Regional Meetings
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/05/Eastern-Regional-Meeting-Presentation-1.png
ORGANIZER;CN="Lakeridge Health":MAILTO:n2@n2canada.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240911T120000
DTEND;TZID=America/Toronto:20240911T130000
DTSTAMP:20240603T191327Z
CREATED:20240603T191327Z
LAST-MODIFIED:20240603T191327Z
UID:12453-1726056000-1726059600@n2canada.ca
SUMMARY:Webinar - Designing effectiveness-implementation hybrid trials in child health research
DESCRIPTION:Webinar objectives:\nThe webinar will introduce effectiveness-hybrid designs\, showcase examples\, and outline important considerations for conducting these types of studies. It will also briefly summarize tensions that may occur in conducting implementation research and mention tools to support implementation planning and execution. \nMeet the speaker!\nMelanie Barwick\, Ph.D.\, C.Psych\, is a Senior Scientist in the Child Health Evaluative Sciences Program of the SickKids’ Research Institute and the SickKids Centre for Global Child Health. She also leads professional and resource development in Dissemination and Implementation Research and Practice as Scientific Director of the Knowledge Translation Program in the SickKids’ Learning Institute. At the University of Toronto\, she is a Professor in the Department of Psychiatry\, Temerty Faculty of Medicine\, and the Dalla Lana School of Public Health (Social and Behavioural Health Sciences\, and the Institute for Health Policy\, Management\, and Evaluation). Her community work includes Chairing the Governing Board for Children’s Mental Health Ontario\, membership on the Editorial Board for the SIRC journal Implementation Research and Practice\, and as an Associate Editor for Frontiers in Health Services – Implementation Science. An internationally recognized expert in dissemination and implementation research and practice\, her health services research program spans many areas of health to improve the implementation of evidence into practice and broaden its reach to support decision-making\, policy\, knowledge\, awareness\, health\, and well-being. She provides professional development in dissemination and implementation practice internationally through the Specialist Knowledge Translation Training™ (SKTT\, for researchers and KT practitioners)\, the Knowledge Translation Professional Certificate™ (KTPC\, for KT practitioners)\, and Planning for Implementation Practice™(PIP).
URL:https://n2canada.ca/event/webinar-designing-effectiveness-implementation-hybrid-trials-in-child-health-research/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/IMPaCT-Webinar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240910
DTEND;VALUE=DATE:20240914
DTSTAMP:20240813T212656Z
CREATED:20240724T230729Z
LAST-MODIFIED:20240813T212656Z
UID:13231-1725926400-1726271999@n2canada.ca
SUMMARY:PxP Virtual Conference
DESCRIPTION:Standing for ‘For Patients\, By Patients’\, PxP 2024 is entirely led by an international team of patient and public partners and is a Patients Included™ event. Our purpose is to share resources\, mentorship and community with patient partners and others involved in health research. Ultimately\, our goal is partnering to make research stronger. \nThis free\, virtual event aims to bring you a wealth of knowledge\, skills and resources on patient engagement in health research. Patient engagement in health research\, also known as patient and public involvement (in the UK) or consumer involvement (in Australia). ‘Patient engagement’ in health research is where patients are research team members. This is different from volunteering to be a research participant where you might help advance research or healthcare\, but a research participant generally does not give input into the research study itself. Whatever language you prefer\, we warmly welcome everyone to attend. \nPxP is a must-attend event for these two reasons: \n\nPxP is specifically For Patients. While there has been excellent progress in the available patient engagement resources\, many of these are designed for other members of the research team. Although we welcome health researchers to join us at the event in September\, our key priority will be patient partners and other people with lived experience.\nWe are led entirely By Patients. Every topic and speaker on the PxP conference program has been chosen by our experienced international committee of patient partners.\n\nFor those based in Europe\, Africa and America\, the dates are September 10-12\, and for those in parts of Asia and Oceania the dates are September 11-13. Please note the timings for Day 3 are different from Days 1 and 2. This is because we would like as many people as possible from across the globe to have a chance to join us live. We would love you to join us! After the event\, we will be hosting recordings on the PxP website which will be freely available. \n2024 Steering Committee hope statement: To unite\, inspire\, and empower patients on their journey to health and wellness. May this summit be a beacon of hope fostering community\, knowledge\, and resilience as we navigate challenges together. Let us stand strong\, advocate boldly\, and transform research and healthcare for a brighter\, healthier future. \nWork on the agenda is nearly complete\, and we look forward to sharing the session and speaker details with you soon. Do not hesitate to reach out if you have any questions: contact@pxphub.org
URL:https://n2canada.ca/event/13231/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/07/Event-Posters-for-Website.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240807T110000
DTEND;TZID=America/Toronto:20240807T120000
DTSTAMP:20240603T190226Z
CREATED:20240603T190216Z
LAST-MODIFIED:20240603T190226Z
UID:12448-1723028400-1723032000@n2canada.ca
SUMMARY:Webinar - Considerations for effective integration of gender and sex in research and clinical trials
DESCRIPTION:Webinar objectives:\nIn this session\, we will explore best practice guidelines for researchers to build more equitable\, reflective\, and inclusive research and clinical trials with respect to gender and sex. We will touch briefly on a variety of topics including\, participant eligibility\, recruitment\, sampling plans and data analysis\, measurement of genders and sexes\, responsiveness across time\, and working with validated scales. The objective is to stimulate critical thought about effective integration of sex and gender in research and clinical trials and to offer some key resources for continued learning. \nMeet the speaker!\nDr. Natalie Rosen (she/her) is a Professor in the Departments of Psychology and Neuroscience and Obstetrics and Gynaecology at Dalhousie University\, Halifax\, Nova Scotia\, Canada. Her research focuses on understanding how couples cope with sexual dysfunction and changes to their sexual relationship —such as during pregnancy and the postpartum period. She is committed to translating her research findings into novel interventions and to sharing evidence-based information with service providers and the public. Dr. Rosen has authored over 150 peer-reviewed publications and she is the current Past-President of the Canadian Sex Research Forum. Dr. Rosen is the Sex and Gender Science Lead for the CIHR-funded Maritimes SPOR Support Unit and has developed several resources to support researchers’ consideration of sex and gender in their work.
URL:https://n2canada.ca/event/webinar-considerations-for-effective-integration-of-gender-and-sex-in-research-and-clinical-trials/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/Central-Regional-Meeting-Presentation-5.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240717T110000
DTEND;TZID=America/Toronto:20240717T123000
DTSTAMP:20240617T174334Z
CREATED:20240617T174320Z
LAST-MODIFIED:20240617T174334Z
UID:12995-1721214000-1721219400@n2canada.ca
SUMMARY:Navigating FDA Regulations for Canadian Clinical Trials
DESCRIPTION:
URL:https://n2canada.ca/event/navigating-fda-regulations-for-canadian-clinical-trials/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/Navigating-FDA-Regulations-Presentation.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240717T110000
DTEND;TZID=America/Toronto:20240717T120000
DTSTAMP:20240603T185843Z
CREATED:20240603T185843Z
LAST-MODIFIED:20240603T185843Z
UID:12444-1721214000-1721217600@n2canada.ca
SUMMARY:Webinar - Racial and Ethnic Diversity in Pediatric Clinical Trials: Current Barriers and a Path Towards Inclusive Clinical Trial Design and Conduct
DESCRIPTION:Webinar objectives: \n\n\nUnderstand the role that historical and ongoing marginalization play in research participation \n\n\nDiscuss how research findings in homogeneous populations are not generalizable to all children \n\n\nDescribe research approaches that can improve diversity and inclusion in pediatric clinical trials \n\n\nMeet the speaker!\nDr Tamorah Lewis is a physician scientist\, Division Head for Clinical Pharmacology and Toxicology at SickKids. In this role\, Dr Lewis helps advance the hospital-wide vision for Precision Child Health and collaborates with multiple clinical Divisions for pharmacology research. Dr Lewis also continues to provide clinical care in the level IV Neonatal ICU at SickKids. The goals of Dr Lewis’ research program are to bring precision therapeutics to the NICU population. Dr Lewis’ interests include PBPK and population pharmacokinetic and pharmacodynamic investigations in neonates and children\, pertaining to both drugs in common use and drugs under development. Her research focuses on the intersection between ontogeny and pharmacogenetic effects on pharmacology of drugs in infants and neonates. In addition to her clinical and research roles\, Dr Lewis is a dedicated advocate for Health Equity. Through publications and talks\, she educates about the need for increased diversity in the biomedical workforce and the importance of diversity and equity in clinical research and clinical care.
URL:https://n2canada.ca/event/webinar-racial-and-ethnic-diversity-in-pediatric-clinical-trials-current-barriers-and-a-path-towards-inclusive-clinical-trial-design-and-conduct/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/Central-Regional-Meeting-Presentation-4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20240618T120000
DTEND;TZID=America/Vancouver:20240618T130000
DTSTAMP:20240603T202530Z
CREATED:20240603T202530Z
LAST-MODIFIED:20240603T202530Z
UID:12472-1718712000-1718715600@n2canada.ca
SUMMARY:Information Session - Clinical Research Professional Certification Program
DESCRIPTION:Have you ever considered achieving professional certification from the Association of Clinical Research Professionals (ACRP)\, Society of Clinical Research Associates (SoCRA) or the Society of Quality Assurance (SQA)? \nTo date\, Clinical Trials BC has supported over 100 professionals in BC to get certified from our  clinical research professional (CRP) certification program! This program provides BC-based researchers financial support and resource support to prepare for the certification exam. \nThe information session will feature presentations on exam content\, benefits of being internationally certified\, exam fee reimbursements and exam preparation materials. Our program facilitators will also help answer questions and share helpful tips to support your journey towards professional designation. \nDon’t miss this opportunity to advance further on your career path. Register to attend. \nLearning objectives: \nAfter the session\, the audience will: \n\nunderstand the different types of certifications and exams\, and how to prepare for them\nlearn about the resources for exam preparation and exam fee reimbursement offered by Clinical Trials BC\nreceive an overview on ClassMarker\, a platform for practice tests and how to navigate the e-community of practice
URL:https://n2canada.ca/event/information-session-clinical-research-professional-certification-program/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/Webinar-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20240611T113000
DTEND;TZID=America/Vancouver:20240611T123000
DTSTAMP:20250324T191410Z
CREATED:20240603T201115Z
LAST-MODIFIED:20250324T191410Z
UID:12463-1718105400-1718109000@n2canada.ca
SUMMARY:Lessons Learned in Undertaking Clinical Trials
DESCRIPTION:We are excited to invite you to the upcoming event\, “Lessons Learned in Undertaking Clinical Trials”\, a comprehensive session designed to provide valuable insights and practical knowledge from experts in the field. Hosted in collaboration with BCCHR\, WHRI\, and IMPaCT\, come hear from Investigators who have undertaken clinical trials in Children’s and Women’s  health as they share their experiences and what they’ve learned along the way. \n* Please note: Due to limited seating capacity we will take in-person registrations on first come first serve basis. \nThis event is a fantastic opportunity for professionals\, researchers\, and trainees involved in clinical trials to learn from the experiences and challenges faced by Investigators working in Perinatal Health.
URL:https://n2canada.ca/event/lessons-learned-in-undertaking-clinical-trials/
LOCATION:Virtual
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/Webinar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20240603T080000
DTEND;TZID=America/Vancouver:20240604T160000
DTSTAMP:20240605T235447Z
CREATED:20240603T183911Z
LAST-MODIFIED:20240605T235447Z
UID:12435-1717401600-1717516800@n2canada.ca
SUMMARY:IMPaCT Summit
DESCRIPTION:
URL:https://n2canada.ca/event/impact-summit/
LOCATION:Sheraton Wall Centre\, 1000 Burrard St\, Vancouver\, BC\, V6Z 2R9\, Canada
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/Central-Regional-Meeting-Presentation-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240528T140000
DTEND;TZID=America/Toronto:20240528T150000
DTSTAMP:20240531T200424Z
CREATED:20240522T204136Z
LAST-MODIFIED:20240531T200424Z
UID:12207-1716904800-1716908400@n2canada.ca
SUMMARY:N2 May Community Forum 2024
DESCRIPTION:Register for the next N2 Canada Community Forum\, where we will celebrate International Clinical Trials Day! Raisa Chowdhury\, Project Coordinator from the Canadian Cancer Trials Network (3CTN) will present their new EDI way finder tool. Additionally\, Sarah Bridges\, Research Coordinator from the Maritime SPOR SUPPORT Unit and the N2 Public Engagement Committee Co-Chair will present their DIY community engagement toolkit.
URL:https://n2canada.ca/event/n2-may-community-forum-2024/
LOCATION:Zoom
CATEGORIES:N2 Community Forum
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/05/N2-May-Community-Forum-640-x-200-px-Presentation.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240424T120000
DTEND;TZID=America/Toronto:20240424T130000
DTSTAMP:20240603T183348Z
CREATED:20240603T183348Z
LAST-MODIFIED:20240603T183348Z
UID:12430-1713960000-1713963600@n2canada.ca
SUMMARY:Webinar - The Basics of Patient/Youth/Caregiver Engagement in Clinical Trials
DESCRIPTION:Meet the speakers!\nJenna Kedy\nJenna Kedy\, a resilient 19-year-old hailing from Halifax\, Nova Scotia\, epitomizes strength and advocacy in the face of adversity. Battling juvenile arthritis and juvenile fibromyalgia from a young age\, Jenna emerged as a relentless fighter\, surviving septic shock and becoming a beacon of hope for others struggling with chronic illness. With a passion for chronic illness advocacy\, Jenna has dedicated five years to patient partnership\, serving as a mentor with Impact Trials and contributing to various initiatives at the IWK Health Centre\, including the Youth Advisory Council and Emergency Department Family Council. Alongside her studies in Family Studies at Mount St Vincent University\, Jenna embodies leadership\, serving as an ambassador for Trufaces and volunteering with organizations such as the Arthritis Society and Girl Guides of Canada. Through her Instagram blog\, “spoonie_jennak\,” Jenna raises awareness for chronic illnesses\, while her role as Royal International Miss Halifax 2024 allows her to amplify her message on a national stage. With an unwavering commitment to advocacy\, Jenna is poised to make a lasting impact on healthcare and disability awareness\, inspiring others to embrace resilience and self-care. \nYan Défossés\nI’m a fervent promoter of engagement and inclusion. Also adept at new technologies\, ask me how the metaverse can promote the development of diverse and authentic partnerships\, and I will invite you to join a dynamic virtual community of practice. I like to add color to discussions with my French Canadian accent and my candid reflections. Before becoming the primary caregiver for my son Liam\, who lives with spinal muscular atrophy (SMA type 1)\, I worked in the media industry where I ran a creative agency. With other great parents\, I co-founded the Quebec chapter of Cure SMA. I never miss an opportunity to be involved and collaborate to improve patient voice.  Over the past decade\, my family has witnessed the evolution of medical care. We closely followed the initial clinical trials\, their approval\, and the intricate negotiations that led to the reimbursement of the first treatments. Today\, our community has three reimbursed treatments available. The neonatal screening\, enables all Canadian children to receive treatment before the onset of symptoms. These achievements are the result of intense collaboration among all stakeholders. Nevertheless\, access to products and services that meet Liam’s health\, education\, and cultural needs remains a challenging journey. These obstacles are often encountered by individuals living with complex medical conditions. Consequently\, I continue to advocate within institutions and organizations at various levels of jurisdiction for better support and partnership between all stakeholders. \nDawn Richards\nDawn Richards\, PhD\, lives with rheumatoid arthritis and osteoarthritis. At Five02 Labs Inc.\, her work combines her analytical chemistry training and her passion to ensure patients inform research and healthcare. She helps people and organizations design and execute their patient engagement initiatives using leading practices and tailoring their approaches to meet their goals and patient partners’ needs. She has contributed to the literature and practice in patient engagement on compensation\, authorship\, recognizing patients as people with skills and who lead fulfilling lives\, and training on patient engagement in research. Dawn is the volunteer Vice President of the Canadian Arthritis Patient Alliance. \nMaureen Smith\nMy commitment and passion for patient engagement and patient partnered research stems from a diagnosis with a rare disease during childhood and frequent flyer status with the healthcare system. I have benefitted both from participating in pediatric and adult clinical trials and collaborating with trialists as a patient partner. I’m especially interested in advancing youth and family engagement in areas of research where it is in its early stages\, such as reporting guidelines. I’m proud to say that I’ve collaborated with research teams and patient groups to advise on co-developing 6 pediatric core outcome sets. In June 2023 I was appointed Adjunct Professor at the University of Toronto Dalla Lana School of Public Health\, a recognition of the expertise I have acquired in patient engagement as a person with lived experience.  I may pop up on Zoom calls in unexpected places as my husband and I explore Canada in our trailer!
URL:https://n2canada.ca/event/webinar-the-basics-of-patient-youth-caregiver-engagement-in-clinical-trials/
LOCATION:Zoom
CATEGORIES:Collaborator Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/Central-Regional-Meeting-Presentation-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20240221T080000
DTEND;TZID=America/Toronto:20240222T170000
DTSTAMP:20240603T185117Z
CREATED:20240603T185117Z
LAST-MODIFIED:20240603T185117Z
UID:12439-1708502400-1708621200@n2canada.ca
SUMMARY:2024 N2 Annual Conference
DESCRIPTION:
URL:https://n2canada.ca/event/2024-n2-annual-conference/
LOCATION:Pheedloop
CATEGORIES:N2 Annual Conference
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/06/N2-Annual-Conference-Lobby-Banner.png
END:VEVENT
END:VCALENDAR